Identification of c-Kit gene mutations in patients with polycythemia vera
Palabras clave : 
C-Kit
Polycythemia
Vera
Mutation
Fecha incorporación: 
2006
Editorial : 
Elsevier
ISSN: 
0145-2126
Cita: 
Fontalba, A., Real P. J., Fernández-Luna, J. L., Agirre, X. et al. Leukemia Research. 2006; 30: 1323–1326
Resumen
Imatinib mesylate has recently been reported to have clinical activity in the treatment of polycythemia vera (PV), suggesting the involvement of one of the kinases targeted by this inhibitor, including c-Kit and PDGFR. Activating c-Kit mutations have been identified in patients with mastocytosis and other myeloid disorders such as acute myeloid leukemia. Thus, we wanted to analyze the presence of mutations of c-Kit in polycythemia vera patients. We found that 7 out of 20 patients carried missense mutations in the c-Kit gene whereas no sequence variation was detected in 15 healthy controls.

Ficheros en este registro:
No hay ficheros asociados a este ítem.


Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.